UnitedHealth Group and Amedisys complete $3.3 billion merger

UnitedHealth Group and Amedisys have completed their $3.3 billion merger following an agreement with the Department of Justice. The merger, announced in June 2023, saw Amedisys becoming a subsidiary of UnitedHealth under the Optum division. The SEC filing confirmed the finalization of the deal, with the DOJ imposing the condition of divesting 164 home health and hospice locations in 19 states.

The divested facilities, which include a palliative care facility, generate approximately $528 million in annual revenue. This divestiture is notable as it is the largest of its kind in outpatient healthcare services to address antitrust concerns raised by the government. The requirement to divest these locations was crucial in ensuring fair competition in the home health and hospice industry.

The legal hurdles faced by the merger arose last November when the DOJ filed a lawsuit against the companies, citing concerns about potential anticompetitive effects. Amedisys, being the largest home health and hospice provider in the country as of 2022, posed a direct competition threat to UnitedHealth. The lawsuit argued that the merger would eliminate this competition permanently, giving UnitedHealth a significant market share exceeding 30% in the home health and hospice services sector.

The resolution of the DOJ’s concerns paved the way for the successful completion of the merger between UnitedHealth Group and Amedisys. With the divestiture requirement met, the two companies can now move forward as a combined entity under UnitedHealth’s ownership. The merger aligns with UnitedHealth’s broader strategic goals, enhancing its position within the healthcare industry and expanding its service offerings to include home health and hospice care.

The collaboration between UnitedHealth and Amedisys signifies a significant milestone in the healthcare landscape, demonstrating the evolving dynamics of the industry. By joining forces, the two companies can leverage their respective strengths and resources to deliver comprehensive and integrated healthcare solutions to a broader patient population. The merger marks a strategic investment in addressing the growing demand for home-based healthcare services and improving patient outcomes through coordinated care delivery models.

Overall, the completion of the $3.3 billion merger represents a strategic move by UnitedHealth Group to strengthen its market presence and diversify its service portfolio. With the integration of Amedisys into its operations, UnitedHealth is poised to drive innovation, improve access to care, and enhance the overall quality of healthcare delivery for patients across the United States.